Sanofi-Aventis growth stifled by Plavix and price cuts
February 15, 2007Sales and Marketing
Figures show that Sanofi-Aventis continued to grow in 2006, despite its complaints about pressure in the US from generic manufacturers …
New HIV therapy to be fast-tracked
February 15, 2007Research and Development
A new treatment for HIV is to be fast-tracked in Europe and the US.Pfizer's new compound maraviroc is to receive …
UK biotech consortium wins major grant for cutting-edge gene therapy
February 14, 2007Research and Development
The EU has granted London-based Ark Therapeutics £1.65 million to fund research into using insect-derived viruses for producing genetic medicines.Ark …
UK pharma and government launch new collaboration
February 14, 2007Research and Development
A collaboration between GlaxoSmithKline, Boehringer Ingelheim, Pfizer and East Lincolnshire PCT has been heralded as the future of healthcare in …
NICE set to appraise obesity treatment Accomplia
February 14, 2007Sales and Marketing
Sanofi-Aventis' obesity treatment Acomplia (rimonabant) will be among the drugs appraised by NICE in its latest works programme. With an …
New anti-clotting antibody enters trials
February 12, 2007Research and Development, Sales and Marketing
European biotech companies ThromboGenics and BioInvent are to start a phase I trial of a new drug which could prove …
Flexing pharma’s competitive muscles
February 12, 2007Sales and Marketing sales, strategy
It is universally acknowledged, almost to the point of cliche, that pharmaceutical companies operate in a highly competitive environment. Ensuring …
GlaxoSmithKline plans five launches for 2007
February 9, 2007Sales and Marketing GSK
GlaxoSmithKline is planning to launch five new products in 2007, bringing to an end a long period for the company …
Cholesterol drugs boost Schering-Plough
February 9, 2007Sales and Marketing Merck, Schering-Plough
A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …
3,000 job losses to help AZ maintain profits and invest in R&D
February 9, 2007Sales and Marketing AZ
AstraZeneca has indicated its plans to shed 3,000 jobs will mainly involve redundancies at its manufacturing facilities, in a renewed …
Momentum growing at specialists Archimedes as lead enters phase III
February 9, 2007Research and Development
Specialist pharmaceutical company Archimedes has reached a vital stage in its plans for growth as its lead product enters phase …
Go-ahead for free prescriptions in Wales despite warnings
February 9, 2007Sales and Marketing NHS, Wales
Wales is set to abolish all NHS prescription charges to patients in a move intended to allow fairer access to …
Arrow purchase adds another string to AZ’s biotech bow
February 9, 2007Research and Development
AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …
Novartis set for ‘unprecedented’ wave of launches
February 9, 2007Sales and Marketing
Novartis is preparing to set a new record for the pharmaceutical industry by launching eight products in the next 12 …
50% drop in UK sales positions reveals fast-changing industry
February 9, 2007Sales and Marketing
Newly released figures show the number of sales representatives taking the ABPI exam dropped 50% in 2006; clear proof that …
Adventis expands into med ed with LeapFrog acquisition
February 8, 2007Medical Communications
Marketing communications group Adventis has acquired med ed agency LeapFrog Medical for more than £2 million to form one of …
Fast-growing Roche leads pharma sector
February 7, 2007Sales and Marketing
Roche has unveiled record-breaking profits for 2006, driven by pharma sales that grew by more than three times the market …
The evolution of the NHS in 2007
February 5, 2007Sales and Marketing NHS, sales, strategy
The NHS will undergo major reorganisation in 2007, just as it has in the nine preceding years of Labour's tenure. …
GPs praised for dramatic fall in unnecessary referrals
January 31, 2007The government has hailed the success of one of its key reforms, practice-based commissioning, saying it has helped some areas …
MorphoSys opens UK headquarters in Oxford
January 31, 2007Research and Development
A leading producer of antibodies for biotech drug research and manufacturing has opened a new UK headquarters in Oxford.MorphoSys generates …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
